Clinical Trial Update: Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression [NA]

View source ↗

Summary

Clinical trial investigating adding maraviroc to antiretroviral therapy for HIV patients with suboptimal CD4 T-cell recovery despite virologic suppression has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Maraviroc (maraviroc)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV Infections | NA | Status: COMPLETED | Results posted: 2012-02-24